Patents

US 9687535 B2: Methods and compositions for the treatment of symptoms of prion diseases

Granted
2017-06-27
Filed
2015-05-15 application 14713178
Type
Utility · 14 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

A therapeutic composition for the treatment of the symptoms of prion diseases and the method for preparing the therapeutic agents is disclosed. The therapeutic composition is a stable pharmaceutical composition comprising one or more digestive and/or pancreatic enzymes. The therapeutic composition may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic composition may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using fecal chymotrypsin level as a biomarker for the presence of a prion disease, or the likelihood of an individual to develop a prion disease is disclosed.

Source: PVGPATDIS, file of 2026-04-10 (ipg170627.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
CUREMARK, LLC 55 patentsUS company or organizationRye, NYCUREMARK, LLC State business registration EXACT high confidence: identical full name and state
CUREMARK LLC Form D issuer EXACT high confidence: identical full name and state
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Joan M. FallonBronxville, NY61PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61KPreparations for medical, dental or toiletry purposesA61K38/54PVGPATDIS, file of 2026-04-10
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms ; compositions or test papers therefor; processes of preparing such compositions; condition-responsive control in microbiological or enzymological processesC12Q1/37PVGPATDIS, file of 2026-04-10
G01NInvestigating or analysing materials by determining their chemical or physical propertiesG01N33/6896PVGPATDIS, file of 2026-04-10
C12YEnzymesC12Y301/01PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2017-01-23Correction
Corrective assignment to correct the assignee name previously recorded at reel: 035755 frame: 0054. assignor(s) hereby confirms the assignment.
FALLON, JOAN M. signed 2013-04-08CUREMARK, LLC RYE, NY41163/628ECORSEXC, file of 2026-09-25
2015-06-01Assignment
Assignment of assignor's interest
FALLON, JOAN M. signed 2013-04-08CUREMARK LLC RYE, NY35755/54ECORSEXC, file of 2026-09-25

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.